Literature DB >> 14683629

Facioscapulohumeral muscular dystrophy.

Rabi Tawil1.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is a dominantly inherited muscular dystrophy with a distinctive clinical presentation. Despite the identification of a causal deletion on chromosome 4q35 over a decade ago, the molecular pathophysiology of FSHD remains unclear. The deleted repeats, though clearly associated with FSHD, do not contain expressed genes. The FSHD-associated deletions must, therefore, influence the expression of one or more genes at a distance from the site of the deletion. Recent studies have suggested potential mechanisms through which such a distant effect could be mediated.

Entities:  

Mesh:

Year:  2004        PMID: 14683629     DOI: 10.1007/s11910-004-0012-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  26 in total

1.  Inheritance of a 38-kb fragment in apparently sporadic facioscapulohumeral muscular dystrophy.

Authors:  F Vitelli; M Villanova; A Malandrini; M Bruttini; M Piccini; L Merlini; G Guazzi; A Renieri
Journal:  Muscle Nerve       Date:  1999-10       Impact factor: 3.217

2.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.

Authors:  Richard J L F Lemmers; Peggy de Kievit; Lodewijk Sandkuijl; George W Padberg; Gert-Jan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

3.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.

Authors:  C Wijmenga; J E Hewitt; L A Sandkuijl; L N Clark; T J Wright; H G Dauwerse; A M Gruter; M H Hofker; P Moerer; R Williamson
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

4.  Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis.

Authors:  R J Lemmers; S M van der Maarel; J C van Deutekom; M J van der Wielen; G Deidda; H G Dauwerse; J Hewitt; M Hofker; E Bakker; G W Padberg; R R Frants
Journal:  Hum Mol Genet       Date:  1998-08       Impact factor: 6.150

Review 5.  Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.

Authors:  R Tawil; D A Figlewicz; R C Griggs; B Weiffenbach
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

6.  Facioscapulohumeral muscular dystrophy in the Dutch population.

Authors:  G W Padberg; R R Frants; O F Brouwer; C Wijmenga; E Bakker; L A Sandkuijl
Journal:  Muscle Nerve Suppl       Date:  1995

7.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy.

Authors:  G W Padberg; O F Brouwer; R J de Keizer; G Dijkman; C Wijmenga; J J Grote; R R Frants
Journal:  Muscle Nerve Suppl       Date:  1995

8.  Scapulothoracic arthrodesis in facioscapulohumeral muscular dystrophy. Review of seventeen procedures with three to twenty-one-year follow-up.

Authors:  W H Bunch; I M Siegel
Journal:  J Bone Joint Surg Am       Date:  1993-03       Impact factor: 5.284

9.  A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Authors:  R Tawil; M P McDermott; S Pandya; W King; J Kissel; J R Mendell; R C Griggs
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

10.  Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy.

Authors:  M Funakoshi; K Goto; K Arahata
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  3 in total

1.  [Facioscapulohumeral muscle dystrophy and heart disease].

Authors:  P Emmrich; V Ogunlade; T Gradistanac; S Daneschnejad; M C Koch; R Schober
Journal:  Z Kardiol       Date:  2005-05

Review 2.  Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.

Authors:  Malihe Mohamadian; Mandana Rastegar; Negin Pasamanesh; Ata Ghadiri; Pegah Ghandil; Mohsen Naseri
Journal:  J Mol Neurosci       Date:  2021-11-02       Impact factor: 3.444

Review 3.  Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review.

Authors:  Tai-Heng Chen; Yan-Zhang Wu; Yung-Hao Tseng
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.